Cancer Biomarkers in Body Fluids

• Muut tekijät: Bianchi, Fabrizio (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Aiheet: Research & information: general; Physics; primary breast cancer; circulating nucleosomes; circulating tumor cells; plasminogen activator inhibitor-1; cytokines; prostate cancer; breast cancer; treatment decisions; exosomes; molecular composition; cancer pathogenesis; diagnostics; therapeutics; leptomeningeal metastasis; cerebrospinal fluid; extracellular vesicle; biomarker; RNA sequencing; small non-coding RNA; microRNA; exo-oncomiRNAS; TWEAK; semen; rheumatoid factor; autoimmunity; autoantibodies; cancer; predictive biomarker; prognostic biomarker; cancer progression; cancer development; immunotherapy; cancer susceptibility; tumor recurrence; tumor load; fecal immunochemical test (FIT); colonoscopy; flexible sigmoidoscopy; liquid biopsy; mRNA; ctDNA; proteins; extracellular vesicles; biomarkers; exosome; lung cancer; miRNA; plasma; serum; volatile organic compounds (VOCs); gas chromatography (GC); mass spectrometry (MS); headspace solid phase microextraction (HS-SPME); breast cancer biomarkers; principal component analysis (PCA); linear discriminant analysis (LDA); principal component regression (PCR); cfDNA; hereditary and familial pancreatic cancer; somatic mutation profiling; potentially druggable genes; uveal melanoma; circulating tumor DNA; next generation sequencing; PKC inhibitor; treatment; response; melanoma; ovarian cancer; lipidomics; lipid; prognosis; ceramide; phospholipid; plasmalogen; patient stratification; outcome; personalized medicine; neuroblastoma; immune monitoring; anti-GD2; IL-2; GM-CSF; ASCT; dinutuximab; anti-PD-1; urothelial cancer; blood biomarkers; NETs; disease modelling; machine learning; metabolic signaling; molecular pathways; plasma metabolites; diagnostic biomarkers; urine; urine liquid biopsy; DNA; sncRNA; bladder cancer; metabolic pathways; metabolism; metabolomics; epigenetics; miRNAs; epigenetic biomarkers; DNA methylation; micro-RNAs; human papillomavirus; oropharyngeal squamous cell carcinoma; treatment de-escalation; E7 oncoprotein; HPV DNA; HPV antibodies; ELISA; cancer biomarkers; diagnosis; early detection; n/a; early diagnosis
• Linkit: DOAB: download the publication; DOAB: description of the publication